G1 Therapeutics Inc (STU:G1H)
€ 6.39 0 (0%) Market Cap: 339.15 Mil Enterprise Value: 327.68 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 32/100

Q2 2021 G1 Therapeutics Inc Earnings Call Transcript

Aug 04, 2021 / 08:30PM GMT
Release Date Price: €14.11 (+0.21%)
Operator

Good day. Thank you for standing by, and welcome to the G1 Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. (Operator Instructions)

I would now like to turn the conference over to your host, Mr. Will Roberts. Please go ahead, sir.

William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Sarah. Good afternoon, everyone, and welcome to the G1 conference call to discuss our second quarter 2021 financial results and business update. The press release on these financial results was issued after market closed this afternoon and can be found in the News section of our corporate website, G1therapeutics.com.

On this call, the team will provide a business overview of the second quarter of 2021, including an update on our launch progress in that period with COSELA which was approved by the U.S. Food and Drug Administration on February 12, 2021,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot